Dawes Fretzin Clinical Research Group-7910 N Shadeland Ave

Indianapolis, Indiana 46256-4697

0 studies enrolling now · 2 studies all time

What they study most

Chronic Spontaneous Urticaria, Plaque Psoriasis

Studies at this site

• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria — Running, not enrolling
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment — Completed